M1CK34 Stock Overview
Provides healthcare services in the United States and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
McKesson Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$892.70 |
52 Week High | US$942.82 |
52 Week Low | US$647.46 |
Beta | 0.52 |
1 Month Change | -1.14% |
3 Month Change | 15.77% |
1 Year Change | n/a |
3 Year Change | 174.68% |
5 Year Change | 426.67% |
Change since IPO | 462.51% |
Recent News & Updates
Recent updates
Shareholder Returns
M1CK34 | BR Healthcare | BR Market | |
---|---|---|---|
7D | -1.1% | 3.4% | 3.3% |
1Y | n/a | -18.7% | -6.9% |
Return vs Industry: Insufficient data to determine how M1CK34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how M1CK34 performed against the BR Market.
Price Volatility
M1CK34 volatility | |
---|---|
M1CK34 Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 5.6% |
10% most volatile stocks in BR Market | 9.9% |
10% least volatile stocks in BR Market | 3.2% |
Stable Share Price: M1CK34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine M1CK34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
McKesson Corporation Fundamentals Summary
M1CK34 fundamental statistics | |
---|---|
Market cap | R$450.17b |
Earnings (TTM) | R$14.91b |
Revenue (TTM) | R$1.94t |
30.3x
P/E Ratio0.2x
P/S RatioIs M1CK34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
M1CK34 income statement (TTM) | |
---|---|
Revenue | US$330.19b |
Cost of Revenue | US$317.29b |
Gross Profit | US$12.89b |
Other Expenses | US$10.36b |
Earnings | US$2.54b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
Earnings per share (EPS) | 19.98 |
Gross Margin | 3.90% |
Net Profit Margin | 0.77% |
Debt/Equity Ratio | -208.9% |
How did M1CK34 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield13%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 00:03 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
McKesson Corporation is covered by 42 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Toung | Argus Research Company |
Gregory Bolan | Avondale Partners |
Eric Coldwell | Baird |